| Status | Study |
| Active, not recruiting |
Study Name: Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma Condition: Cushing Syndrome Adrenocortical Carcinoma Date: 2017-04-26 Interventions: Drug: Abiraterone Acetate Cohort 1: |
| Not yet recruiting |
Study Name: Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Peritoneal Carcinomatosis Date: 2017-04-02 Interventions: Drug: Cisplatin |
| Recruiting |
Study Name: Familial Investigations of Childhood Cancer Predisposition Condition: Acute Leukemia Adenomatous Polyposis Adrenocortical Carcin Date: 2017-02-08 |
| Not yet recruiting |
Study Name: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors Condition: Adrenal Cortex Carcinoma Adult Alveolar Soft Part Sarcoma Date: 2016-08-15 Interventions: Drug: Cabozantinib S-malate Gi |
| Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
| Not yet recruiting |
Study Name: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor Condition: Functional Pancreatic Neuroendocrine Tumor Malignant Somatostatinoma Date: 2016-07-10 Interventions: Drug: Capecitabine Given PO |
| Not yet recruiting |
Study Name: Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism Condition: Primary Aldosteronism Adrenal Adenoma Date: 2016-04-26 Interventions: Device: Radiofrequency ablation The radiofrequency system will be used as the RFA generator device stand |
| Not yet recruiting |
Study Name: Expression of Different Proliferation Biomarkers in Adreno-cortical Tumors Condition: Adrenal Cortex Neoplasms Adrenal Cortex Diseases Date: 2016-04-19 |
| Active, not recruiting |
Study Name: Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer Condition: Metastatic Carcinoma in the Adrenal Cortex Recurrent Adrenal Cortex Carcinoma Date: 2016-03-16 Interventions: Other: Laboratory Biomarker Analysis |
| Recruiting |
Study Name: Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma Condition: Adrenocortical Carcinoma Date: 2016-02-01 Interventions: Drug: Pembrolizumab |